Abstract
Ankylosing spondylitis is a disease that shows a young age of onset (less than 40 years old), inflammatory back pain, sacroiliitis and a strong association with HLA-B27. Yet some recently reported cases have presented with a late age of onset (more than 55 years old), atypical clinical presentations and a low response to NSAIDs, and this has also been named late onset spondyloarthropathy (LOSPA). As compared with early onset spondyloarthropathy (EOSPA), the LOSPA patients more frequently suffer with combined peripheral arthritis and inflammatory systemic symptoms and a high ESR and CRP level, but they lack the typical axial symptoms. Yet there have been few reports about late onset ankylosing spondylitis (LOAS). The previous cases of LOSPA and LOAS were managed with NSAIDs, steroids, methotrexate and sulfasalazine, but none were managed with TNF antagonists. LOAS is rare and difficult for management because of the patients' older age and the lack of experiences with this malady, so we report here on the four cases of LOAS that were successfully treated by TNF antagonists.
REFERENCES
1). Chung JW., Park TJ., Choi GS., Park HJ., Kim HA., Park HS, et al. A case of late onset peripheral spondyloarthropathy. J Korean Rheum Assoc. 2007. 14:85–90.
2). Dubost JJ., Sauvezie B. Late onset peripheral spondyloarthropathy. J Rheumatol. 1989. 16:1214–7.
3). Olivieri I., Oranges GS., Sconosciuto F., Padula A., Ruju GP., Pasero G. Late onset peripheral seronegative spondyloarthropathy: report of two additional cases. J Rheumatol. 1993. 20:390–3.
4). Olivieri I., Padula A., Pierro A., Favaro L., Oranges GS., Ferri S. Late onset undifferentiated seronegative spondyloarthropathy. J Rheumatol. 1995. 22:899–903.
5). Dubost JJ., Soubrier M., Ristori JM., Guillemot C., Bussiere JL., Sauvezie B. Late-onset spondyloarthropathy mimicking reflex sympathetic dystrophy syndrome. Joint Bone Spine. 2003. 70:226–9.
6). Ponce A., Sanmarti R., Orellana C., Munoz-Gomez J. Spondyloarthropathy presenting as a polymyalgia rheumatica-like syndrome. Clin Rheumatol. 1997. 16:614–6.
7). Gran JT., Husby G. Ankylosing spondylitis: a comparative study of patients in an epidemiological survey, and those admitted to a department of rheumatology. J Rheumatol. 1984. 11:788–93.
8). Carbone LD., Cooper C., Michet CJ., Atkinson EJ., O'Fallon WM., Melton LJ. 3rd. Ankylosing spondylitis in Rochester, Minnesota, 1935-1989. Is the epidemiology changing? Arthritis Rheum. 1992. 35:1476–82.
9). Amor B., Dougados M., Khan MA. Management of refractory ankylosing spondylits and related spondyloarthropathies. Rheum Dis Clin North Am. 1995. 21:117–28.
10). Dubost JJ., Sauvezie B. Current aspects of inflammatory rheumatic diseases in elderly patients. Rev Rhum Mal Osteoartic. 1992. 59:S37–42.
11). Caplanne DF., Tubach JM. Le Parc, Late onset spondylarthropathy: clinical and biological comparison with early onset patients. Ann Rheum Dis. 1997. 56:176–9.
12). Feldtkeller E., Khan MA., van der Heijde D., van der Linden S., Braun J. Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int. 2003. 23:61–6.
13). Toussirot E., Wendling D. Late-onset ankylosing spondylitis and related spondylarthropathies: clinical and radiological characteristics and pharmacological treatment options. Drugs Aging. 2005. 22:451–69.